632 related articles for article (PubMed ID: 16813525)
21. Wnt signaling induces gene expression of factors associated with bone destruction in lung and breast cancer.
Johnson RW; Merkel AR; Page JM; Ruppender NS; Guelcher SA; Sterling JA
Clin Exp Metastasis; 2014 Dec; 31(8):945-59. PubMed ID: 25359619
[TBL] [Abstract][Full Text] [Related]
22. Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice.
Cheng JN; Frye JB; Whitman SA; Ehsani S; Ali S; Funk JL
Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38715255
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance and pathogenic function of connective tissue growth factor (CTGF/CCN2) in osteolytic mandibular squamous cell carcinoma.
Shimo T; Kubota S; Goda T; Yoshihama Y; Kurio N; Nishida T; Ng PS; Endo K; Takigawa M; Sasakii A
Anticancer Res; 2008; 28(4C):2343-8. PubMed ID: 18751416
[TBL] [Abstract][Full Text] [Related]
24. A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.
Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Pandey R; Funk JL
Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923316
[TBL] [Abstract][Full Text] [Related]
25. PTHrP(12-48) Modulates the Bone Marrow Microenvironment and Suppresses Human Osteoclast Differentiation and Lifespan.
Kamalakar A; Washam CL; Akel NS; Allen BJ; Williams DK; Swain FL; Leitzel K; Lipton A; Gaddy D; Suva LJ
J Bone Miner Res; 2017 Jul; 32(7):1421-1431. PubMed ID: 28370412
[TBL] [Abstract][Full Text] [Related]
26. cAMP-response-element-binding protein positively regulates breast cancer metastasis and subsequent bone destruction.
Son J; Lee JH; Kim HN; Ha H; Lee ZH
Biochem Biophys Res Commun; 2010 Jul; 398(2):309-14. PubMed ID: 20599715
[TBL] [Abstract][Full Text] [Related]
27. Over-production of parathyroid hormone-related peptide results in increased osteolytic skeletal metastasis by prostate cancer cells in vivo.
Rabbani SA; Gladu J; Harakidas P; Jamison B; Goltzman D
Int J Cancer; 1999 Jan; 80(2):257-64. PubMed ID: 9935208
[TBL] [Abstract][Full Text] [Related]
28. TGF-beta1-induced connective tissue growth factor (CCN2) expression in human renal proximal tubule epithelial cells requires Ras/MEK/ERK and Smad signalling.
Phanish MK; Wahab NA; Hendry BM; Dockrell ME
Nephron Exp Nephrol; 2005; 100(4):e156-65. PubMed ID: 15855807
[TBL] [Abstract][Full Text] [Related]
29. Roles of PKC, PI3K and JNK in multiple transduction of CCN2/CTGF signals in chondrocytes.
Yosimichi G; Kubota S; Nishida T; Kondo S; Yanagita T; Nakao K; Takano-Yamamoto T; Takigawa M
Bone; 2006 Jun; 38(6):853-63. PubMed ID: 16431170
[TBL] [Abstract][Full Text] [Related]
30. Matrix rigidity induces osteolytic gene expression of metastatic breast cancer cells.
Ruppender NS; Merkel AR; Martin TJ; Mundy GR; Sterling JA; Guelcher SA
PLoS One; 2010 Nov; 5(11):e15451. PubMed ID: 21085597
[TBL] [Abstract][Full Text] [Related]
31. Lysophosphatidic acid upregulates connective tissue growth factor expression in osteoblasts through the GPCR/PKC and PKA pathways.
Yu ZL; Li DQ; Huang XY; Xing X; Yu RQ; Li Z; Li ZB
Int J Mol Med; 2016 Feb; 37(2):468-74. PubMed ID: 26743816
[TBL] [Abstract][Full Text] [Related]
32. Molecular mechanisms of tumor-bone interactions in osteolytic metastases.
Chirgwin JM; Guise TA
Crit Rev Eukaryot Gene Expr; 2000; 10(2):159-78. PubMed ID: 11186331
[TBL] [Abstract][Full Text] [Related]
33. Inhibition effects of total flavonoids from Sculellaria barbata D. Don on human breast carcinoma bone metastasis via downregulating PTHrP pathway.
Zheng X; Kang W; Liu H; Guo S
Int J Mol Med; 2018 Jun; 41(6):3137-3146. PubMed ID: 29512770
[TBL] [Abstract][Full Text] [Related]
34. PTHrP signaling targets cyclin D1 and induces osteoblastic cell growth arrest.
Datta NS; Chen C; Berry JE; McCauley LK
J Bone Miner Res; 2005 Jun; 20(6):1051-64. PubMed ID: 15883646
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor-beta in osteolytic breast cancer bone metastases.
Guise TA; Chirgwin JM
Clin Orthop Relat Res; 2003 Oct; (415 Suppl):S32-8. PubMed ID: 14600590
[TBL] [Abstract][Full Text] [Related]
36. Erlotinib inhibits osteolytic bone invasion of human non-small-cell lung cancer cell line NCI-H292.
Furugaki K; Moriya Y; Iwai T; Yorozu K; Yanagisawa M; Kondoh K; Fujimoto-Ohuchi K; Mori K
Clin Exp Metastasis; 2011 Oct; 28(7):649-59. PubMed ID: 21688034
[TBL] [Abstract][Full Text] [Related]
37. Animal and cellular models of hepatocellular carcinoma bone metastasis: establishment and characterisation.
Hou R; Wang YW; Liang HF; Zhang ZG; Liu ZM; Zhang BH; Zhang BX; Chen XP
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1931-43. PubMed ID: 25820528
[TBL] [Abstract][Full Text] [Related]
38. The parathyroid hormone-related protein receptor is expressed in breast cancer bone metastases and promotes autocrine proliferation in breast carcinoma cells.
Hoey RP; Sanderson C; Iddon J; Brady G; Bundred NJ; Anderson NG
Br J Cancer; 2003 Feb; 88(4):567-73. PubMed ID: 12592371
[TBL] [Abstract][Full Text] [Related]
39. Novel angiogenic inhibitor DN-9693 that inhibits post-transcriptional induction of connective tissue growth factor (CTGF/CCN2) by vascular endothelial growth factor in human endothelial cells.
Kondo S; Tanaka N; Kubota S; Mukudai Y; Yosimichi G; Sugahara T; Takigawa M
Mol Cancer Ther; 2006 Jan; 5(1):129-37. PubMed ID: 16432171
[TBL] [Abstract][Full Text] [Related]
40. Characterization of neuroblastoma bone invasion/metastasis in established bone metastatic model of SY5Y and KCNR cell lines.
Zhao H; Cai W; Li S; Da Z; Sun H; Ma L; Lin Y; Zhi D
Childs Nerv Syst; 2013 Jul; 29(7):1097-105. PubMed ID: 23559392
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
